Kasper Andersen
Physician at Department of Medical Sciences; Clinical Epidemiology
- E-mail:
- Kasper.Andersen@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset, Ingång 40, 5 tr
751 85 Uppsala - Postal address:
- Akademiska sjukhuset, Ingång 40, 5 tr
751 85 UPPSALA
Researcher at UCR-Uppsala Clinical Research center
- E-mail:
- kasper.andersen@ucr.uu.se
- Visiting address:
- Dag Hammarskjölds väg 38
- Postal address:
- Uppsala Science Park
Dag Hammarskjölds väg 38
751 85 UPPSALA
Download contact information for Kasper Andersen at UCR-Uppsala Clinical Research center
Publications
Recent publications
-
Part of Läkartidningen, 2025
-
Part of Journal of the American Heart Association, 2025
- DOI for Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA-MI Trial
- Download full text (pdf) of Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA-MI Trial
-
Behandling av tromboembolisk pumlonell hypertension
Part of Läkartidningen, p. 148-151, 2025
-
Nya riktlinjer för akuta koronara syndromet
Part of Läkartidningen, 2024
-
Part of Läkartidningen, 2024
All publications
Articles in journal
-
Part of Läkartidningen, 2025
-
Part of Journal of the American Heart Association, 2025
- DOI for Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA-MI Trial
- Download full text (pdf) of Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA-MI Trial
-
Nya riktlinjer för akuta koronara syndromet
Part of Läkartidningen, 2024
-
Part of Läkartidningen, 2024
-
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure
Part of NEJM evidence, 2024
-
Part of Circulation, p. 1161-1170, 2024
-
Part of Contemporary Clinical Trials Communications, 2024
- DOI for Patients' experiences of clinical trial participation involving a product remotely assessing study drug adherence
- Download full text (pdf) of Patients' experiences of clinical trial participation involving a product remotely assessing study drug adherence
-
Fokus på individuell behandling vid akut koronart syndrom utan ST-höjning
Part of Läkartidningen, 2021
-
Part of Läkartidningen, 2020
-
Part of Circulation, p. 743-750, 2020
-
Part of Circulation, p. 910-920, 2019
-
Body size and risk of atrial fibrillation: a cohort study of 1.1 million young men
Part of Journal of Internal Medicine, p. 346-355, 2018
-
Skeletal muscle morphology and risk of cardiovascular disease in elderly men
Part of European Journal of Preventive Cardiology, p. 231-239, 2015
-
Part of BMJ-BRITISH MEDICAL JOURNAL, 2015
- DOI for Exercise capacity and muscle strength and risk of vascular disease and arrhythmia in 1.1 million young Swedish men: cohort study
- Download full text (pdf) of Exercise capacity and muscle strength and risk of vascular disease and arrhythmia in 1.1 million young Swedish men: cohort study
-
Anthropometric measures and risk of atrial fibrillation - a cohort study of 1.2 million young men
Part of European Heart Journal, p. 910-910, 2015
-
Part of Circulation Heart Failure, p. 701-708, 2014
-
Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study
Part of European Heart Journal, p. 3624-3631, 2013
-
Total and leisure time physical activity and risk of heart failure: a prospective cohort study
Part of European Heart Journal, p. 1052-1052, 2012
-
Muscle Morphology And Risk Of Cardiovascular Disease
Part of Journal of Hypertension, 2010
Articles, review/survey
-
Behandling av tromboembolisk pumlonell hypertension
Part of Läkartidningen, p. 148-151, 2025